Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Illicit drug use and HIV treatment outcomes in a US cohort.

Cofrancesco J Jr, Scherzer R, Tien PC, Gibert CL, Southwell H, Sidney S, Dobs A, Grunfeld C.

AIDS. 2008 Jan 30;22(3):357-65. doi: 10.1097/QAD.0b013e3282f3cc21.

2.

Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.

Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):93-9. doi: 10.1097/QAI.0b013e3181900129.

PMID:
19295339
3.

Drug use and other risk factors related to lower body mass index among HIV-infected individuals.

Quach LA, Wanke CA, Schmid CH, Gorbach SL, Mwamburi DM, Mayer KH, Spiegelman D, Tang AM.

Drug Alcohol Depend. 2008 May 1;95(1-2):30-6. doi: 10.1016/j.drugalcdep.2007.12.004.

4.

Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Lucas GM, Cheever LW, Chaisson RE, Moore RD.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):251-9.

PMID:
11464144
5.

Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection.

Hartel DM, Schoenbaum EE, Lo Y, Klein RS.

Clin Infect Dis. 2006 Aug 15;43(4):525-31.

6.

The impact of illicit drug use and substance abuse treatment on adherence to HAART.

Hicks PL, Mulvey KP, Chander G, Fleishman JA, Josephs JS, Korthuis PT, Hellinger J, Gaist P, Gebo KA; HIV Research Network..

AIDS Care. 2007 Oct;19(9):1134-40.

7.

Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.

Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L.

AIDS Patient Care STDS. 2014 Mar;28(3):136-43. doi: 10.1089/apc.2013.0329.

8.

Experience of pain among women with advanced HIV disease.

Richardson JL, Heikes B, Karim R, Weber K, Anastos K, Young M.

AIDS Patient Care STDS. 2009 Jul;23(7):503-11. doi: 10.1089/apc.2008.0128.

9.

HIV and recent illicit drug use interact to affect verbal memory in women.

Meyer VJ, Rubin LH, Martin E, Weber KM, Cohen MH, Golub ET, Valcour V, Young MA, Crystal H, Anastos K, Aouizerat BE, Milam J, Maki PM.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):67-76. doi: 10.1097/QAI.0b013e318289565c.

10.

Prevalence and factors associated with dry skin in HIV infection: the FRAM study.

Lee D, Benson CA, Lewis CE, Grunfeld C, Scherzer R.

AIDS. 2007 Oct 1;21(15):2051-7.

11.

The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.

Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, Mcknight C, Bramson H, Friedman SR.

Addiction. 2007 May;102(5):778-85.

PMID:
17506155
12.

Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems.

Walley AY, Cheng DM, Libman H, Nunes D, Horsburgh CR Jr, Saitz R, Samet JH.

AIDS. 2008 Jan 30;22(3):415-20. doi: 10.1097/QAD.0b013e3282f423f8.

13.

Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.

Milloy MJ, King A, Kerr T, Adams E, Samji H, Guillemi S, Wood E, Montaner J.

J Int AIDS Soc. 2016 Apr 18;19(1):20617. doi: 10.7448/IAS.19.1.20617.

14.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
15.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
16.

The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.

Raffa JD, Grebely J, Tossonian H, Wong T, Viljoen M, Khara M, Mead A, McLean M, Duncan F, Petkau AJ, DeVlaming S, Conway B.

Drug Alcohol Depend. 2007 Jul 10;89(2-3):306-9.

PMID:
17383117
17.

Sexual dysfunction in men who abuse illicit drugs: a preliminary report.

Bang-Ping J.

J Sex Med. 2009 Apr;6(4):1072-80.

PMID:
18093094
18.

Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.

Murri R, Guaraldi G, Lupoli P, Crisafulli R, Marcotullio S, von Schloesser F, Wu AW.

AIDS Patient Care STDS. 2009 Jan;23(1):35-9. doi: 10.1089/apc.2007.0248.

PMID:
19183079
19.

Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort.

Jones CY, Tang AM, Forrester JE, Huang J, Hendricks KM, Knox TA, Spiegelman D, Semba RD, Woods MN.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):475-82.

PMID:
17019373
20.

Pain is associated with heroin use over time in HIV-infected Russian drinkers.

Tsui JI, Cheng DM, Coleman SM, Blokhina E, Bridden C, Krupitsky E, Samet JH.

Addiction. 2013 Oct;108(10):1779-87. doi: 10.1111/add.12274.

Supplemental Content

Support Center